You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (3) |
Back to Search
THE VALSARTAN SAGA: SCIENCE, MYTHS AND REALTIES
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-RSC-008
- By: BALDACCHINO, Stephania (University of Malta, Pharmacy Department, Malta)
- Co-author(s): Stephania Baldacchino: Pharmacy Department, University of Malta, Msida, Malta
Anthony Serracino-Inglott: Malta Medicines Authority , Malta Medicines Authority, San Gwann, Malta;Pharmacy Department, University of Malta, Msida, Malta
Annalise Attard: Malta Medicines Authority, Malta Medicines Authority, San Gwann, Malta
Caroline Muscat: Malta Medicines Authority, Malta Medicines Authority, San Gwann, Malta - Abstract:
Background
Detection of N-nitrosodimethylamine (NDMA), a potential human carcinogen in the manufacture of the valsartan active pharmaceutical ingredient, led to the withdrawal of several contaminated valsartan medicinal products.
Methods
Part I involved an in-depth analysis of the significance of the NDMA impurity in valsartan medicines through a
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026